| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 3.01e-11 | 4 | 5 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.05e-08 | 30 | 5 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 3.38e-08 | 31 | 5 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin binding | 9.03e-06 | 739 | 5 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.07e-05 | 206 | 5 | 3 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 2.27e-05 | 265 | 5 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.98e-05 | 320 | 5 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.21e-05 | 326 | 5 | 3 | GO:0001217 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.13e-05 | 1244 | 5 | 4 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.76e-05 | 1271 | 5 | 4 | GO:0000987 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.34e-04 | 1459 | 5 | 4 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.10e-04 | 560 | 5 | 3 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.17e-04 | 566 | 5 | 3 | GO:0001216 | |
| GeneOntologyMolecularFunction | transcription factor binding | 5.05e-04 | 753 | 5 | 3 | GO:0008134 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.79e-03 | 1160 | 5 | 3 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 2.82e-03 | 1356 | 5 | 3 | GO:0060090 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.17e-03 | 1412 | 5 | 3 | GO:0000981 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 2.74e-11 | 4 | 5 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 3.47e-11 | 35 | 5 | 4 | GO:0048333 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 6.84e-11 | 5 | 5 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 1.37e-10 | 6 | 5 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 3.83e-10 | 8 | 5 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 8.20e-10 | 10 | 5 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 1.13e-09 | 11 | 5 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | mesoderm formation | 1.16e-09 | 82 | 5 | 4 | GO:0001707 | |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 1.40e-09 | 86 | 5 | 4 | GO:0048332 | |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 3.11e-09 | 15 | 5 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 3.11e-09 | 15 | 5 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 4.65e-09 | 17 | 5 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 5.57e-09 | 18 | 5 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 5.57e-09 | 18 | 5 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 6.19e-09 | 124 | 5 | 4 | GO:0001704 | |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 1.21e-08 | 23 | 5 | 3 | GO:0001710 | |
| GeneOntologyBiologicalProcess | mesoderm development | 1.61e-08 | 157 | 5 | 4 | GO:0007498 | |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 2.49e-08 | 29 | 5 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell differentiation | 3.72e-08 | 33 | 5 | 3 | GO:2000737 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in formation of primary germ layer | 5.30e-08 | 37 | 5 | 3 | GO:0060795 | |
| GeneOntologyBiologicalProcess | gastrulation | 5.38e-08 | 212 | 5 | 4 | GO:0007369 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 5.75e-08 | 38 | 5 | 3 | GO:0035987 | |
| GeneOntologyBiologicalProcess | endoderm formation | 1.26e-07 | 49 | 5 | 3 | GO:0001706 | |
| GeneOntologyBiologicalProcess | stem cell division | 1.26e-07 | 49 | 5 | 3 | GO:0017145 | |
| GeneOntologyBiologicalProcess | regulation of cell fate commitment | 1.60e-07 | 53 | 5 | 3 | GO:0010453 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 3.50e-07 | 338 | 5 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 5.59e-07 | 80 | 5 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | endoderm development | 7.46e-07 | 88 | 5 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | regulation of stem cell differentiation | 1.07e-06 | 99 | 5 | 3 | GO:2000736 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.39e-06 | 108 | 5 | 3 | GO:0035019 | |
| GeneOntologyBiologicalProcess | cell fate specification | 2.05e-06 | 123 | 5 | 3 | GO:0001708 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.48e-06 | 131 | 5 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | response to retinoic acid | 2.48e-06 | 131 | 5 | 3 | GO:0032526 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 3.73e-06 | 150 | 5 | 3 | GO:0090288 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle | 4.12e-06 | 155 | 5 | 3 | GO:0045931 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 6.89e-06 | 713 | 5 | 4 | GO:0048598 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 8.42e-06 | 750 | 5 | 4 | GO:0048729 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 8.46e-06 | 197 | 5 | 3 | GO:0030509 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 8.99e-06 | 201 | 5 | 3 | GO:0051302 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.10e-05 | 215 | 5 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.10e-05 | 215 | 5 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.15e-05 | 218 | 5 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.47e-05 | 237 | 5 | 3 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.57e-05 | 242 | 5 | 3 | GO:0098727 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 3.16e-05 | 306 | 5 | 3 | GO:0048863 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.60e-05 | 347 | 5 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 5.19e-05 | 1186 | 5 | 4 | GO:0007167 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 7.41e-05 | 407 | 5 | 3 | GO:0045787 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 7.68e-05 | 412 | 5 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 9.66e-05 | 445 | 5 | 3 | GO:0141091 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 9.72e-05 | 1390 | 5 | 4 | GO:0045944 | |
| GeneOntologyBiologicalProcess | embryo development | 1.11e-04 | 1437 | 5 | 4 | GO:0009790 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.22e-04 | 482 | 5 | 3 | GO:0007178 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 1.25e-04 | 1483 | 5 | 4 | GO:0048646 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 2.28e-04 | 594 | 5 | 3 | GO:0007346 | |
| GeneOntologyBiologicalProcess | cell division | 3.65e-04 | 697 | 5 | 3 | GO:0051301 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 6.55e-04 | 850 | 5 | 3 | GO:0071363 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 7.13e-04 | 875 | 5 | 3 | GO:0045596 | |
| GeneOntologyBiologicalProcess | response to growth factor | 7.33e-04 | 883 | 5 | 3 | GO:0070848 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 1.10e-03 | 1014 | 5 | 3 | GO:0000278 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.23e-03 | 1053 | 5 | 3 | GO:0000122 | |
| GeneOntologyBiologicalProcess | response to lipid | 1.49e-03 | 1126 | 5 | 3 | GO:0033993 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.75e-03 | 1190 | 5 | 3 | GO:0008284 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 1.89e-03 | 1220 | 5 | 3 | GO:0051093 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | 2.05e-03 | 1256 | 5 | 3 | GO:0051726 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.81e-03 | 1399 | 5 | 3 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.89e-03 | 1413 | 5 | 3 | GO:1902679 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 3.21e-03 | 377 | 5 | 2 | GO:0062197 | |
| GeneOntologyCellularComponent | condensed chromosome | 3.07e-05 | 307 | 5 | 3 | GO:0000793 | |
| GeneOntologyCellularComponent | chromatin | 3.18e-03 | 1480 | 5 | 3 | GO:0000785 | |
| MousePheno | absent primitive endoderm | 1.84e-09 | 9 | 5 | 3 | MP:0011185 | |
| MousePheno | absent extraembryonic ectoderm | 9.98e-09 | 15 | 5 | 3 | MP:0002583 | |
| MousePheno | absent embryonic epiblast | 1.23e-08 | 16 | 5 | 3 | MP:0011184 | |
| MousePheno | abnormal primitive endoderm morphology | 4.44e-08 | 24 | 5 | 3 | MP:0011183 | |
| MousePheno | abnormal inner cell mass apoptosis | 9.85e-08 | 31 | 5 | 3 | MP:0010380 | |
| MousePheno | abnormal extraembryonic ectoderm morphology | 9.85e-08 | 31 | 5 | 3 | MP:0010736 | |
| MousePheno | disorganized extraembryonic tissue | 1.43e-07 | 35 | 5 | 3 | MP:0002582 | |
| MousePheno | abnormal embryonic epiblast morphology | 2.92e-06 | 94 | 5 | 3 | MP:0003886 | |
| MousePheno | abnormal bilaminar embryonic disk morphology | 3.73e-06 | 102 | 5 | 3 | MP:0012103 | |
| MousePheno | abnormal inner cell mass morphology | 5.08e-06 | 113 | 5 | 3 | MP:0002718 | |
| MousePheno | abnormal embryonic tissue cell apoptosis | 2.06e-05 | 180 | 5 | 3 | MP:0013503 | |
| MousePheno | abnormal blastocyst morphology | 6.12e-05 | 259 | 5 | 3 | MP:0004957 | |
| MousePheno | abnormal preimplantation embryo morphology | 7.97e-05 | 283 | 5 | 3 | MP:0014137 | |
| MousePheno | abnormal embryonic tissue physiology | 9.20e-05 | 297 | 5 | 3 | MP:0008932 | |
| MousePheno | embryonic lethality between implantation and somite formation, complete penetrance | 1.06e-04 | 311 | 5 | 3 | MP:0011096 | |
| MousePheno | embryonic lethality between implantation and somite formation | 1.38e-04 | 340 | 5 | 3 | MP:0006205 | |
| MousePheno | embryonic lethality between implantation and placentation, complete penetrance | 4.46e-04 | 506 | 5 | 3 | MP:0011095 | |
| MousePheno | embryonic lethality between implantation and placentation | 6.18e-04 | 565 | 5 | 3 | MP:0009850 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | 1.54e-03 | 772 | 5 | 3 | MP:0014259 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | 1.58e-03 | 779 | 5 | 3 | MP:0014257 | |
| MousePheno | abnormal extraembryonic tissue morphology | 2.47e-03 | 908 | 5 | 3 | MP:0002086 | |
| MousePheno | abnormal embryonic tissue morphology | 4.49e-03 | 1116 | 5 | 3 | MP:0002085 | |
| MousePheno | embryonic lethality prior to organogenesis | 5.58e-03 | 1204 | 5 | 3 | MP:0013292 | |
| MousePheno | abnormal apoptosis | 7.79e-03 | 1353 | 5 | 3 | MP:0001648 | |
| MousePheno | abnormal programmed cell death | 7.90e-03 | 1360 | 5 | 3 | MP:0014355 | |
| MousePheno | embryonic lethality prior to tooth bud stage | 8.29e-03 | 1383 | 5 | 3 | MP:0013293 | |
| Domain | Homeobox | 1.91e-05 | 234 | 5 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.96e-05 | 236 | 5 | 3 | PS00027 | |
| Domain | HOX | 1.98e-05 | 237 | 5 | 3 | SM00389 | |
| Domain | Homeobox_dom | 2.03e-05 | 239 | 5 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 2.03e-05 | 239 | 5 | 3 | PS50071 | |
| Domain | Homeodomain-like | 3.04e-03 | 332 | 5 | 2 | IPR009057 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.04e-07 | 301 | 4 | 4 | MM15983 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.42e-06 | 101 | 4 | 3 | MM15829 | |
| Pubmed | EED and KDM6B coordinate the first mammalian cell lineage commitment to ensure embryo implantation. | 2.71e-14 | 11 | 5 | 4 | 23671187 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 1.43e-12 | 3 | 5 | 3 | 31891567 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 23200040 | ||
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 1.43e-12 | 3 | 5 | 3 | 25753417 | |
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 1.43e-12 | 3 | 5 | 3 | 25410303 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 24929238 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 19447925 | ||
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 1.43e-12 | 3 | 5 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 1.43e-12 | 3 | 5 | 3 | 23329853 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 1.43e-12 | 3 | 5 | 3 | 30814124 | |
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 1.43e-12 | 3 | 5 | 3 | 17211451 | |
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 1.43e-12 | 3 | 5 | 3 | 23770853 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 1.43e-12 | 3 | 5 | 3 | 14728807 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 1.43e-12 | 3 | 5 | 3 | 30837263 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 15502159 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 1.43e-12 | 3 | 5 | 3 | 26751055 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 20539761 | ||
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 1.43e-12 | 3 | 5 | 3 | 15916719 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 1.43e-12 | 3 | 5 | 3 | 27939294 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 1.43e-12 | 3 | 5 | 3 | 17352742 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 33334884 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 1.43e-12 | 3 | 5 | 3 | 30846691 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 21499299 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 1.43e-12 | 3 | 5 | 3 | 21874018 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 1.43e-12 | 3 | 5 | 3 | 17554338 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 1.43e-12 | 3 | 5 | 3 | 23054952 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 1.43e-12 | 3 | 5 | 3 | 26660234 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 1.43e-12 | 3 | 5 | 3 | 16845474 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 1.43e-12 | 3 | 5 | 3 | 21194951 | |
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 1.43e-12 | 3 | 5 | 3 | 33107035 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 1.43e-12 | 3 | 5 | 3 | 25005472 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 18584034 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 24681518 | ||
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 1.43e-12 | 3 | 5 | 3 | 24527385 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 21969378 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 16773043 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 18086680 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 20661723 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 29245050 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 23665121 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 1.43e-12 | 3 | 5 | 3 | 17360937 | |
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 1.43e-12 | 3 | 5 | 3 | 26733157 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 22337995 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 22388986 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 21187909 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 16313224 | ||
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 1.43e-12 | 3 | 5 | 3 | 18177668 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 35976266 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 26549484 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 23071603 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 16791199 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 1.43e-12 | 3 | 5 | 3 | 16541131 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 1.43e-12 | 3 | 5 | 3 | 16259959 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 1.43e-12 | 3 | 5 | 3 | 22142851 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 16501172 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 18290762 | ||
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 1.43e-12 | 3 | 5 | 3 | 24462001 | |
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 1.43e-12 | 3 | 5 | 3 | 33665763 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 12609610 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 1.43e-12 | 3 | 5 | 3 | 23333380 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 1.43e-12 | 3 | 5 | 3 | 22172669 | |
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 1.43e-12 | 3 | 5 | 3 | 18024963 | |
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 1.43e-12 | 3 | 5 | 3 | 19582141 | |
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 27125671 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 18442017 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 24227785 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 21119109 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 32145514 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 26760119 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 19703398 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 22028025 | ||
| Pubmed | 1.43e-12 | 3 | 5 | 3 | 17204467 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 1.43e-12 | 3 | 5 | 3 | 18097409 | |
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 1.43e-12 | 3 | 5 | 3 | 28457890 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 1.43e-12 | 3 | 5 | 3 | 19800316 | |
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 1.43e-12 | 3 | 5 | 3 | 28636920 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 1.43e-12 | 3 | 5 | 3 | 18436640 | |
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 1.43e-12 | 3 | 5 | 3 | 24461999 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 1.43e-12 | 3 | 5 | 3 | 23103910 | |
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 1.43e-12 | 3 | 5 | 3 | 15494369 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 19366700 | ||
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 25743411 | ||
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 31262352 | ||
| Pubmed | Prion protein expression regulates embryonic stem cell pluripotency and differentiation. | 5.71e-12 | 4 | 5 | 3 | 21483752 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 16166633 | ||
| Pubmed | Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter. | 5.71e-12 | 4 | 5 | 3 | 28093523 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 22315219 | ||
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 21304588 | ||
| Pubmed | Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. | 5.71e-12 | 4 | 5 | 3 | 16894029 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 33058869 | ||
| Pubmed | GATA-1 directly regulates Nanog in mouse embryonic stem cells. | 5.71e-12 | 4 | 5 | 3 | 26296469 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 17518637 | ||
| Pubmed | Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells. | 5.71e-12 | 4 | 5 | 3 | 21810410 | |
| Pubmed | Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. | 5.71e-12 | 4 | 5 | 3 | 21490431 | |
| Pubmed | 5.71e-12 | 4 | 5 | 3 | 22787153 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr12p13 | 5.81e-04 | 353 | 5 | 2 | chr12p13 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 1.94e-07 | 67 | 4 | 3 | 519 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 4.00e-10 | 10 | 5 | 3 | MM741 | |
| Coexpression | MIKKELSEN_PLURIPOTENT_STATE_UP | 1.21e-09 | 14 | 5 | 3 | MM810 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.05e-06 | 125 | 5 | 3 | MM1065 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 8.15e-06 | 247 | 5 | 3 | MM1081 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 1.03e-05 | 267 | 5 | 3 | MM984 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_DN | 5.65e-04 | 199 | 5 | 2 | M5146 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#5 | 1.27e-05 | 232 | 5 | 3 | Arv_SC-hpx_blastocyst_500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#1 | 1.27e-05 | 232 | 5 | 3 | Arv_SC-H9hpx_500_K1 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 3.41e-05 | 323 | 5 | 3 | ratio_SC_vs_ECTO_500_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_500_k-means-cluster#5 | 4.95e-05 | 366 | 5 | 3 | ratio_SC_vs_EB_500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.19e-04 | 492 | 5 | 3 | Arv_SC-hpx_blastocyst_500 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_500 | 1.19e-04 | 492 | 5 | 3 | PCBC_ratio_SC_vs_ECTO_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | 1.19e-04 | 492 | 5 | 3 | Arv_SC-H9hpx_500 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_500 | 1.21e-04 | 494 | 5 | 3 | PCBC_ratio_SC_vs_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_CD34+_top-relative-expression-ranked_500 | 1.21e-04 | 494 | 5 | 3 | PCBC_SC_CD34+_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.29e-04 | 505 | 5 | 3 | Arv_SC-H9hpx_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.33e-04 | 510 | 5 | 3 | Arv_SC-hpx_blastocyst_1000_K3 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.43e-04 | 523 | 5 | 3 | ratio_SC_vs_ECTO_1000_K1 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.57e-04 | 540 | 5 | 3 | ratio_SC_vs_MESO_1000_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.70e-04 | 554 | 5 | 3 | Arv_SC_fibroblast_1000_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.73e-04 | 557 | 5 | 3 | Arv_SC-HD_1000_K1 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.29e-04 | 613 | 5 | 3 | ratio_SC_vs_EB_1000_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.46e-04 | 768 | 5 | 3 | ratio_SC_vs_MESO_2500_K3 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.57e-04 | 145 | 5 | 2 | JC_iEC_1000_K4 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.23e-04 | 860 | 5 | 3 | ratio_SC_vs_ECTO_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.21e-04 | 945 | 5 | 3 | Arv_SC-hpx_blastocyst_2500_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.08e-04 | 978 | 5 | 3 | ratio_SC_vs_EB_2500_K5 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000 | 9.17e-04 | 981 | 5 | 3 | PCBC_DE_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#5 | 9.17e-04 | 981 | 5 | 3 | Arv_SC-H9hpx_2500_K5 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromBlastocyst-derived-iPSC_top-relative-expression-ranked_1000 | 9.17e-04 | 981 | 5 | 3 | PCBC_DE_blastocyst_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000 | 9.25e-04 | 984 | 5 | 3 | PCBC_ratio_SC_vs_EB_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_CD34+_top-relative-expression-ranked_1000 | 9.25e-04 | 984 | 5 | 3 | PCBC_SC_CD34+_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000 | 9.25e-04 | 984 | 5 | 3 | PCBC_ratio_SC_vs_ECTO_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 9.30e-04 | 986 | 5 | 3 | Arv_SC_fibroblast_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | 9.30e-04 | 986 | 5 | 3 | Arv_SC-HD_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 9.30e-04 | 986 | 5 | 3 | PCBC_SC_fibroblast_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | 9.33e-04 | 987 | 5 | 3 | Arv_SC-H9hpx_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 9.33e-04 | 987 | 5 | 3 | Arv_SC-hpx_blastocyst_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_top-relative-expression-ranked_1000 | 9.39e-04 | 989 | 5 | 3 | PCBC_SC_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 9.50e-04 | 993 | 5 | 3 | PCBC_SC_blastocyst_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000 | 9.50e-04 | 993 | 5 | 3 | PCBC_ratio_SC_vs_MESO-5_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.31e-03 | 1108 | 5 | 3 | Arv_SC_fibroblast_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.33e-03 | 1113 | 5 | 3 | Arv_SC-HD_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.47e-03 | 1152 | 5 | 3 | Arv_SC-LF_2500_K5 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 1.87e-03 | 295 | 5 | 2 | ratio_SC_vs_MESO_500_K5 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.14e-03 | 316 | 5 | 2 | JC_iEC_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_500_k-means-cluster#3 | 2.50e-03 | 342 | 5 | 2 | Arv_SC-LF_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.91e-03 | 369 | 5 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | ratio_StemCell-derived-from_CD34-iPSC_vs_StemCell-fibro_top-relative-expression-ranked_2500_k-means-cluster#4 | 4.64e-03 | 468 | 5 | 2 | ratio_SC-cbCD34_vs_SC-fibro_2500_K4 | |
| CoexpressionAtlas | ratio_StemCell-derived-from_CD34-iPSC_vs_StemCell-blastocyst_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.66e-03 | 469 | 5 | 2 | ratio_SC-cbCD34_vs_SC-blastocyst_2500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody-derived-from_CD34-iPSC_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.97e-03 | 485 | 5 | 2 | ratio_EB-cbCD34_vs_EB-fibro_2500_K2 | |
| CoexpressionAtlas | ratio_StemCell-blastocyst_vs_StemCell-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.99e-03 | 486 | 5 | 2 | ratio_SC-blastocyst_vs_SC-fibro_2500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody-derived-from_CD34-iPSC_vs_EmbryoidBody-blastocyst_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.99e-03 | 486 | 5 | 2 | ratio_EB-cbCD34_vs_EB-blastocyst_2500_K3 | |
| CoexpressionAtlas | ratio_StemCell-fibro_vs_StemCell-blastocyst_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.07e-03 | 490 | 5 | 2 | ratio_SC-fibro_vs_SC-blastocyst_2500_K1 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_inducedDefinitiveEndoderm_fromFibroblast-derived-iPSC_top-relative-expression-ranked_500 | 5.11e-03 | 492 | 5 | 2 | PCBC_DE_fibroblast_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_500 | 5.14e-03 | 493 | 5 | 2 | Arv_SC-LF_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 5.16e-03 | 494 | 5 | 2 | PCBC_SC_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 5.18e-03 | 495 | 5 | 2 | PCBC_SC_fibroblast_500 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_500 | 5.18e-03 | 495 | 5 | 2 | PCBC_ratio_SC_vs_MESO-5_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_top-relative-expression-ranked_500 | 5.18e-03 | 495 | 5 | 2 | PCBC_SC_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-DefinitiveEndoderm_top-relative-expression-ranked_500 | 5.20e-03 | 496 | 5 | 2 | PCBC_DE_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody-fibro_vs_EmbryoidBody-derived-from_CD34-iPSC_top-relative-expression-ranked_2500_k-means-cluster#2 | 5.47e-03 | 509 | 5 | 2 | ratio_EB-fibro_vs_EB-cbCD34_2500_K2 | |
| CoexpressionAtlas | ratio_StemCell-blastocyst_vs_cbCD34_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.59e-03 | 515 | 5 | 2 | ratio_SC-blastocyst_vs_cbCD34_2500_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody-fibro_vs_EmbryoidBody-blastocyst_top-relative-expression-ranked_2500_k-means-cluster#1 | 5.66e-03 | 518 | 5 | 2 | ratio_EB-fibro_vs_EB-blastocyst_2500_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.47e-03 | 675 | 5 | 2 | Arv_SC-LF_1000_K3 | |
| ToppCell | TCGA-Testes|World / Sample_Type by Project: Shred V9 | 7.99e-05 | 128 | 5 | 2 | a09b0e221b8749510002304e4d34d6a2eb8867e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 193 | 5 | 2 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.98e-04 | 186 | 3 | 2 | 966_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.05e-04 | 189 | 3 | 2 | 2800_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A | 2.13e-04 | 193 | 3 | 2 | 1805_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 2.15e-04 | 194 | 3 | 2 | 4662_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.18e-04 | 195 | 3 | 2 | 5618_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A | 2.18e-04 | 195 | 3 | 2 | 1214_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 196 | 3 | 2 | 5343_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; HL60; HG-U133A | 2.20e-04 | 196 | 3 | 2 | 2045_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; HL60; HG-U133A | 2.22e-04 | 197 | 3 | 2 | 1372_DN | |
| Drug | Lymecycline [992-21-2]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 3 | 2 | 3514_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.22e-04 | 197 | 3 | 2 | 5810_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 3 | 2 | 3433_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 2.22e-04 | 197 | 3 | 2 | 2837_DN | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.24e-04 | 198 | 3 | 2 | 5529_DN | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.27e-04 | 199 | 3 | 2 | 959_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.27e-04 | 199 | 3 | 2 | 7172_UP | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 200 | 3 | 2 | 2838_DN | |
| Drug | Glucose | 2.42e-04 | 1420 | 3 | 3 | ctd:D005947 | |
| Drug | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | 2.55e-04 | 211 | 3 | 2 | ctd:C009618 | |
| Drug | Ciguatoxins | 4.03e-03 | 845 | 3 | 2 | ctd:D002922 | |
| Disease | colon cancer (implicated_via_orthology) | 3.85e-10 | 11 | 5 | 3 | DOID:219 (implicated_via_orthology) | |
| Disease | precuneus cortex volume measurement | 2.09e-06 | 14 | 5 | 2 | EFO_0010326 | |
| Disease | reticulocyte measurement | 1.18e-02 | 1053 | 5 | 2 | EFO_0010700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WVQATGWCNNIAWNV | 1471 | O15054 | |
| WSNQTWNNSTWSNQT | 196 | Q9H9S0 | |
| WNNSTWSNQTQNIQS | 201 | Q9H9S0 | |
| WNTQTWCTQSWNNQA | 221 | Q9H9S0 | |
| WCTQSWNNQAWNSPF | 226 | Q9H9S0 | |
| WSNQTWNNSTWSNQT | 196 | Q6NSW7 | |
| WNNSTWSNQTQNIQS | 201 | Q6NSW7 | |
| WNTQTWCTQSWNNQA | 221 | Q6NSW7 | |
| WCTQSWNNQAWNSPF | 226 | Q6NSW7 | |
| FSWLWSWSEQNTNEQ | 431 | Q96RL7 | |
| PMWSNQTWNNSTWSN | 121 | Q8N7R0 | |
| QTWNNSTWSNQTQNI | 126 | Q8N7R0 | |
| STWSNQTQNIQSWSN | 131 | Q8N7R0 | |
| QTWCTQSWNNQAWNS | 151 | Q8N7R0 |